BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 22, 2010
View Archived Issues
Memantine reduces "off" time in Parkinson's disease
Read More
PYM-50028 can be delivered to patients with PD at preclinically efficacious doses
Read More
Proximagen Neuroscience claims new SSAO inhibitors
Read More
New JAK3 kinase inhibitors identified by Roche
Read More
Novartis claims new chemokine CXCR2 receptor antagonists
Read More
Astellas submits MAA for mirabegron in Japan
Read More
Taxus Element paclitaxel-eluting stent system launched in Europe
Read More
Roche amends trial protocols for taspoglutide phase III program
Read More
Phase I/II trial of new proapoptotic agent APR-246 advances
Read More
PX-478 shows antitumor activity in phase I trial in advanced solid tumors
Read More
177Lu-J591 shows safety and preliminary efficacy in metastatic CRPC
Read More
ALD-518 improves rheumatoid arthritis symptoms in phase II trial
Read More
FDA recommends approval of emergency contraceptive ulipristal
Read More
Bionomics completes phase I trial of BNC-210 for anxiety
Read More
Mitsubishi Tanabe's Remicade approved for ulcerative colitis in Japan
Read More
FDA committee recommends additional clinical testing to support flibanserin NDA
Read More
Valeant and Biovail agree to merge
Read More
Hematide shows promise to treat anemia in phase III trials in CRF
Read More
BL-1020 improves schizophrenia symptoms in phase IIb trial
Read More
Amplyx Pharmaceuticals presents novel carbapenems
Read More
Zydus receives permission for phase I trial of ZYOG-1 in India
Read More
Lodotra now available in 13 European countries for RA
Read More
Sosei to acquire Activus Pharma
Read More
FDA advises on phase III palifosfamide trial in metastatic soft tissue sarcoma
Read More
Exelixis regains rights to XL-184
Read More